TFO
AGIO icon

Tarbox Family Office’s Agios Pharmaceuticals AGIO Stock Holding History

Tarbox Family Office’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22
Closed -$1K – 1065
2021
Q4 		$1K Hold
22
– – ﹤0.01% 966
2021
Q3 		$1K Hold
22
– – ﹤0.01% 1007
2021
Q2 		$1K Hold
22
– – ﹤0.01% 1017
2021
Q1 		$1K Hold
22
– – ﹤0.01% 985
2020
Q4 		$1K Hold
22
– – ﹤0.01% 949
2020
Q3 		$1K Hold
22
– – ﹤0.01% 897
2020
Q2 		$1K Sell
22
-28
-56% -$1.3K ﹤0.01% 889
2020
Q1 		$2K Buy
50
+22
+79% +$1.02K ﹤0.01% 591
2019
Q4 		$1K Buy
+28
New +$1.06K ﹤0.01% 917
2019
Q3 		– Sell
-23
Closed -$1K – 1088
2019
Q2 		$1K Hold
23
– – ﹤0.01% 875
2019
Q1 		$2K Hold
23
– – ﹤0.01% 480
2018
Q4 		$1K Buy
23
+7
+44% +$432 ﹤0.01% 533
2018
Q3 		$1K Hold
16
– – ﹤0.01% 559
2018
Q2 		$1K Hold
16
– – ﹤0.01% 545
2018
Q1 		$1K Hold
16
– – ﹤0.01% 555
2017
Q4 		$1K Hold
16
– – ﹤0.01% 539
2017
Q3 		$1K Hold
16
– – ﹤0.01% 532
2017
Q2 		$1K Hold
16
– – ﹤0.01% 518
2017
Q1 		$1K Hold
16
– – ﹤0.01% 521
2016
Q4 		$1K Hold
16
– – ﹤0.01% 486
2016
Q3 		$1K Hold
16
– – ﹤0.01% 473
2016
Q2 		$1K Hold
16
– – ﹤0.01% 467
2016
Q1 		$1K Buy
+16
New +$684 ﹤0.01% 481

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Tarbox Family Office's AGIO Position: Q1 2022 in Review

Tarbox Family Office sold out of Agios Pharmaceuticals (AGIO) in Q1 2022, closing a stake of 22 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in AGIO in Q1 2016 and held it in 23 quarters. The position peaked at $2K in Q1 2020. 161 funds tracked by Wall St. Rank hold AGIO as of Q1 2022.

  • Tarbox Family Office reported no remaining Agios Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
  • Tarbox Family Office sold 22 Agios Pharmaceuticals shares in Q1 2022, an estimated $1K.
  • Tarbox Family Office first reported a position in Agios Pharmaceuticals in Q1 2016 and held it in 23 quarters.
  • Tarbox Family Office's Agios Pharmaceuticals position peaked at $2K in Q1 2020.
  • 161 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2022.

Based on Tarbox Family Office's 13F filing for Q1 2022, filed 25 Apr 2022.